Alzheimer’s Wrap-Up[ed note: Michael Jorrin, who I like call “Doc Gumshoe,” is a longtime medical writer who shares his thoughts with us a couple times a month — his articles are non-financial in nature, his words and opinions are his own, and you can see his bio and his past pieces here. Enjoy!] Indulge me while […]
Articles
[ed. note: Michael Jorrin, who I like to call “Doc Gumshoe,” writes about health and medicine for us from time to time. His columns are not generally focused on investments, though this one does include some commentary about a number of specific companies (most are not publicly traded). His words and opinions are his own, […]
[ed note: This is another installment from our favorite medical writer, Doc Gumshoe (no, he’s not a doctor, but we like the way he analyzes and explains medical issues for our readers). Since he’s talking about specific companies this time, we’ve restricted the piece to the Irregulars and have inserted some comments about the stocks […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
Hello, I came across this pitch from MoneyMapPress, that this new drug the FDA approved lets the user gain superhuman he...
#team great company w/ expensive stock at the moment, waiting for a better entry price...
So far, I've had a 65% win ratio on the options trades and 25% win ratio on the stocks. No where near what was promised....
Energous... we covered that pitch here: https://www.stockgumshoe.com/reviews/nova-x-report/what-the-heck-is-nanocrystal-...